Advertisement
Advertisement
CTMX
CytomX Therapeutics, Inc.
1.98
USDSponsored
0.00
0.00%
Nov 10, 15:59 UTC -5
Closed
After-Market
1.97
-0.01
-0.51%
CytomX Therapeutics, Inc. (CTMX)
CytomX Therapeutics, Inc. Financial Snapshot
| Market Cap | 429.47M |
| Beta | 2.23 |
| Earnings Per Share (EPS) | -0.50 |
| Price-to-Book (P/B) Ratio | 1.32 |
| Operating Margin | -435.21% |
| Total Debt/Equity (D/E) | 0.00% |
| P/E Ratio | -- |
| Return on Equity (ROE) | -38.46% |
| Current Ratio | 7.82% |
| Free Cash Flow | -27.26M |
